Handbook of Outpatient Hysteroscopy: A complete guide to diagnosis and therapy

Handbook of Outpatient Hysteroscopy: A complete guide to diagnosis and therapy

Volumn , Issue , 2005, Pages 1-289

  Justin Clark, T ^a   Gupta, Janesh K ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85179239972     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13545     Document Type: Book

References (95)

1. Jeffcoate SL. In: de Swiet M and Chamberlain G, eds. Endocrinology in Basic Science in Obstetrics and Gynaecology, 2nd edn. London: Churchill Livingstone, 1992, Chapter 7.
2. Last RJ. Abdomen. In: McMinn RMH, ed. Last’s Anatomy, Regional and Applied, 9th edn. London: Churchill Livingstone, 1994, Chapter 5.
3. Clark TJ, Gupta JK. Outpatient hysteroscopy. Obstetrician and Gynaecologist 2002;4:217–21; [erratum] 2003;5:37.
4. Department of Health. Day Surgery: operational guide, 2002. [Available at www.publications.doh.gov. uk/daysurgery, accessibility verified 1 May 2004.]
5. Netten A, Curtis L. Unit Costs of Health and Social Care. University of Kent at Canterbury: Personal Social Services Research Unit, 2000. [Available at www.ukc.ac.uk/PSSRU/, accessibility verified September 15, 2004.]
6. Brill AI. Energy systems for operative hysteroscopy. Obstet Gynecol Clin North Am 2000;27:317–26.
7. Cicinelli E, Schonauer LM, Barba B, Tartagni M, Luisi D, Di Naro E. Tolerability and cardiovascular complications of outpatient diagnostic minihysteroscopy compared with conventional hysteroscopy. J Am Assoc Gynecol Laparosc 2003;10:399–402.
8. Medical Devices Agency. Decontamination of endoscopes. Device Bulletin MDA DB2002(05) 2002. [Available at www.medical-devices.gov.uk, accessibility verified July 30, 2004.]
9. Shankar M, Davidson A, Taub N, Habiba M. Randomised comparison of distension media for outpatient hysteroscopy. Br J Obstet Gynaecol 2004;111:57–62.
10. Unfried G, Wieser F, Albrecht A, Kaider A, Nagele F. Flexible versus rigid endoscopes for outpatient hysteroscopy: a prospective randomized clinical trial. Hum Reprod 2001;16:168–71.
11. Cicinelli E, Parisi C, Galantino P, Pinto V, Barba B, Schonauer S. Reliability, feasibility, and safety of minihysteroscopy with a vaginoscopic approach: experience with 6,000 cases. Fertil Steril 2003;80:199–202.
12. Clark TJ, Voit D, Song F, Hyde C, Gupta JK, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and disease: A systematic review. JAMA 2002;288:1610–21.
13. Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 1988;158:489–92.
14. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ 2000;320:279–82.
15. Tahir MM, Bigrigg MA, Browning JJ, Brookes ST, Smith PA. A randomised controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage. Br J Obstet Gynaecol 1999;106:1259–64.
16. Bachmann LM, ter Riet G, Clark TJ, Gupta JK, Khan KS. Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta Obstet Gynecol Scand 2003;82:564–69.
17. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610–21.
18. Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand 2003;82:493–504.
19. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002;81:799–816.
20. Smith-Bindman R, Kerlikowske K, Feldstein VA et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510–17.
21. Clark TJ, Barton PM, Gupta JK, Khan KS. Ambulatory diagnosis of endometrial cancer in women with postmenopausal bleeding. West Midlands Health Technology Assessment Collaboration Report 2003. University of Birmingham (in press, but will be available at www.publichealth.bham.ac.uk).
22. Clark TJ, Mann CH, Shah N, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: A systematic review. Br J Obstet Gynecol 2002;109:313–21.
23. Clark TJ, Voit D, Gupta JK, Hyde C, Song FS, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610–22.
24. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002;81:799–816.
25. Smith-Bindman R, Kerlikowske K, Feldstein VA et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510–17.
26. Clark TJ, Mann CH, Shah N, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia: A systematic review. Acta Obstet Gynecol Scand 2001;80:784–93.
27. Clark TJ, Voit D, Gupta JK, Hyde C, Song FS, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610–22.
28. Kurman RJ, Kaminski PF, Norris HJ. The behaviour of endometrial hyperplasia: A long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer 1985;56:403–12.
29. Sturridge F, Guillebaud J. Gynaecological aspects of the levonorgestrel-releasing intrauterine system. Br J Obstet Gynaecol 1997;104:285–9.
30. Wells M, Sturdee DW, Barlow DH et al. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow-up study. BMJ 2002;325:239.
31. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942–4.
32. Hays J, Ockene JK, Brunner RL et al. Women’s Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–54.
33. Nagele F, O’Connor H, Baskett TF, Davies A, Mohammed H, Magos AL. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding. Fertil Steril 1996;65:1145–50.
34. Rossouw JE, Anderson GL, Prentice RL et al. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.
35. Spencer CP, Cooper AJ, Whitehead MI. Management of abnormal bleeding in women receiving hormone replacement therapy. BMJ 1997; 315: 37–42.
36. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres’ ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 2000; 356:881–7.
37. Fung MF, Reid A, Faught W et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol 2003;91:154–9.
38. Gardner FJ, Konje JC, Abrams KR et al. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial. Lancet 2000;356:1711–17.
39. Neven P, Vergote I. Should tamoxifen users be screened for endometrial lesions? Lancet 1998;351:155–7.
40. Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998;79:62–70.
41. Bain C, Parkin DE, Cooper KG. Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? A randomised comparison. Br J Obstet Gynaecol 2002;109:805–11.
42. Coulter A, Kelland A, Long AEA. The management of menorrhagia. Eff Health Care Bull 1995;9.
43. Dijkhuizen FP, Mol BW, Bongers MY, Brolmann HA, Heintz A. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. Int J Gynecol Obstet 2003;83:45–52.
44. Royal College of Obstetricians and Gynaecologists. The Initial Management of Menorrhagia. Evidence-Based Clinical Guideline No.4. London: RCOG Press, 1999.
45. Royal College of Obstetricians and Gynaecologists. The Management of Menorrhagia in Secondary Care. Evidence-Based Clinical Guideline No.5. London: RCOG Press, 1999.
46. Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol 2002;100:445–50.
47. Rosenthal AN, Panoskaltsis T, Smith T, Soutter WP. The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. Br J Obstet Gynaecol 2001;108:103–6.
48. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314–18.
49. Campo R, Molinas CR, Rombauts L et al. Prospective multicentre randomized controlled trial to evaluate factors influencing the success rate of office diagnostic hysteroscopy. Hum Reprod 2005;20:258–63.
50. Guida M, Pellicano M, Zullo F et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod 2003;18:840–3.
51. Gupta JK, Clark TJ, More S, Pattison H. Patient anxiety and experiences associated with an outpatient ‘one-stop’ ‘see and treat’ hysteroscopy clinic. Surg Endosc 2004;18:1099–104.
52. Lau WC, Lo WK, Tam WH, Yuen PM. Paracervical anaesthesia in outpatient hysteroscopy: a randomised double-blind placebo-controlled trial. Br J Obstet Gynaecol 1999;106:356–9.
53. Nagele F, Lockwood G, Magos AL. Randomised placebo controlled trial of mefenamic acid for premedication at outpatient hysteroscopy: a pilot study. Br J Obstet Gynaecol 1997;104:842–4.
54. United Kingdom Academy of Medical Royal Colleges and their Faculties. Implementing and Ensuring Safe Sedation Practice for Healthcare Procedures in Adults 2001. pp.1–21. [Available at www.rcoa. ac.uk/docs/safesedationpractice.pdf, accessibility verified 6 May 2004.]
55. Hurskainen R, Teperi J, Rissanen P et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273–7.
56. Hurskainen R, Teperi J, Rissanen P A et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow up. JAMA 2004;291:1456–63.
57. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
58. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
59. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001;108:74–86.
60. Bettocchi S, Ceci O, Di Venere R et al. Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr bipolar electrode. Hum Reprod 2002;17:2435–8.
61. Fernandez H, Gervaise A, de Tayrac R. Operative hysteroscopy for infertility using normal saline solution and a coaxial bipolar electrode: a pilot study. Hum Reprod 2000;15:1773–5.
62. Gynecare Versapoint bipolar electrosurgery system. (Available at www.jnjgateway.com/public/GBENG/ VERSAPOINT_epi.pdf, accessibility verified 10 September 2004.).
63. Hunter DC, Cooper DW, Phillips G. Gas embolism during VersaPoint hysteroscopic myomectomy. Gynecol Endosc 2001;10:261–4.
64. Vleugels MPH. Normal saline field bipolar electrosurgery in hysteroscopy: report of the first 163 cases. Gynaecol Endosc 2001;10:349–53.
65. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 2000;21:180–3.
66. DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 2002;100:3–7.
67. Clark TJ, Godwin J, Khan KS, Gupta JK. Ambulatory endoscopic treament of symptomatic benign endometrial polyps: A feasibility study. Gynaecol Endosc 2002;11:91–7.
68. Clark TJ, Khan KS, Gupta JK. Current practice for the treament of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in UK. Eur J Obstet Gynecol Reprod Biol 2002;103:65–7.
69. Vilodre LC, Bertat R, Petters R, Reis FM. Cervical polyp as risk factor for hysteroscopically diagnosed endometrial polyps. Gynecol Obstet Invest 1997;44:191–5.
70. Clark TJ, Mahajan D, Sunder P, Gupta JK. Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study. Eur J Obstet Gynecol Reprod Biol 2002; 100:237–42.
71. Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999;93:743–48.
72. Farrugia M, McMillan L. Versapoint in the treatment of focal intra-uterine pathology in an outpatient clinic setting. Ref Gynecologie Obstetrique 2000;7:169–73.
73. Hart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999;106:700–5.
74. Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC. Management of uterine leiomyomata: what do we really know? Obstet Gynecol 2002;100:8–17.
75. Abbott JA, Hawe J, Garry R. Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10:491–5.
76. Cooper J, Gimpelson RJ. Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49: 267–73.
77. Garside R, Stein K, Wyatt K, Round A, Price A. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. Health Technol Assess 2004;8:1–155.
78. Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding: a Cochrane review. Hum Reprod 2002;17:2795–806.
79. National Institute for Clinical Excellence. Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding. Technology Appraisal Guidance 78, April 2004. [Available at www.nice.org.uk/TA078guidance]
80. Al-Inany H. Intrauterine adhesions. Acta Obstet Gynecol Scand 2001; 80: 986–93.
81. Fernandez H, Gervaise A, de Tayrac R. Operative hysteroscopy for infertility using normal saline solution and a coaxial bipolar electrode: a pilot study. Hum Reprod 2000;15:1773–5.
82. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000;73:1–14.
83. Lee A, Ying YK, Novy MJ. Hysteroscopy and hysterosalpingography and tubal ostial polyps in infertility patients. J Reprod Med 1997;42:337–41.
84. Shushan A, Rojansky N. Should hysteroscopy be part of the basic infertility work-up? Hum Reprod 1999;14:1923–4.
85. Cooper JM, Carignan CS, Cher D, Kerin JF. Selective Tubal Occlusion Procedure 2000 Investigators’ Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003;102:59–67.
86. Dillon A. Hysteroscopic Sterilization by Tubal Cannulation and Placement of Intrafallopian Implants. National Institute for Clinical Excellence Interventional Procedure Guidance 44 (ISBN 1–84257–524–4) 2004. [Available at: www.nice.org.uk/IPG044distributionlist, accessibility verified 12 March, 2004.]
87. French R, Cowan F, Mansour D et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004;3:CD001776.
88. Kerin JF, Cooper JM, Price T et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003;18:1223–30.
89. National Institute for Clinical Excellence Interventional Procedures Programme. Interventional Procedure Overview of Hysteroscopic Sterilisation by Tubal Cannulation and Placement of Intrafallopian Implant 2003. [Available at: www.nice.org.uk/IP218overview, accessibility verified 12 March, 2004.]
90. Royal College of Obstetricians and Gynaecologists. Male and Female Sterilisation. Evidence-Based Clinical Guideline No. 4. London: RCOG Press, 2004.
91. Bolam v Friern Hospital Management Committee (1957) 1 W.L.R. 582.
92. Bolitho (deceased) v City and Hackney Health Authority (1987) 4 All E R 771.
93. Chapron C, Devroey P, Dubuisson JB, Pouly JL, Vercellini P. ESHRE guidelines for training, accreditation and monitoring in gynaecological endoscopy. Hum Reprod 1997;12:867–8.
94. Department of Health. Good practice in consent implementation guide: consent to examination or treatment 2001. (Available at http://www.dh.gov.uk/assetRoot/04/01/90/61/04019061.pdf)
95. Maynard v W Midlands Regional Health Authority (1984) 1 W.L.R. 634.